What is Elanco Animal Health Incorporated's (ELAN) StockRank?

MoatMap's StockRank for Elanco Animal Health Incorporated (ELAN) is 70/100, with a Buy signal. This is a composite score combining Quality (45), Value (44), and Momentum (75) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Elanco Animal Health Incorporated have an economic moat?

Elanco Animal Health Incorporated (ELAN) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Elanco Animal Health Incorporated a buy, hold, or sell?

MoatMap's current signal for Elanco Animal Health Incorporated (ELAN) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated (ELAN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

ELAN

BuyHot Air

Elanco Animal Health Incorporated · Healthcare · United States · $12.0B · Avg Vol: $173M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-3.0%

D/E

0.6x

Dividend %

—

COMPANY DESCRIPTION

Elanco Animal Health Incorporated is a global leader in animal health, dedicated to developing, manufacturing, and marketing innovative products and solutions for pets and livestock across more than 90 countries. The company establishes a strong competitive moat through its diversified portfolio of essential parasiticides, vaccines, and therapeutic products, coupled with significant R&D investment and deep relationships with veterinarians and livestock producers. Elanco's focus on animal well-being and food security positions it as a resilient player in the growing animal health market.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	4.4B	4.4B	4.4B	4.7B	2.2%	5.0B	5.1B	5.4B	7.0%
EPS	-0.15	-2.50	0.68	-0.47	—	-0.41	—	—	—
Shares	474.2M	492.8M	494.4M	497.0M	+4.8%	499.4M	—	—	—
Debt	5.8B	5.8B	4.3B	4.0B	-11.7%	4.2B	—	—	—
Equity	7.3B	6.2B	6.1B	6.5B	-3.5%	—	—	—	—
Op CF	452.0M	271.0M	541.0M	560.0M	7.4%	617.0M	—	—	—
Inv CF	-179.0M	-169.0M	1.2B	-279.0M	—	—	—	—	—
Fin CF	-549.0M	-83.0M	-1.5B	-275.0M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)-10.8%

SMA 50SMA 200

$23.55

RSI (14)

41.7

52W High

$27.98

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

0.7%45.6

ROE

-3.0%41.1

GP/Assets

20.8%46.5

Op. Margin

8.6%59.6

FCF/Assets

2.8%59.5

Piotroski

549.3

Int. Cover

0.3x36.8

D/E Ratio

0.64x22.9

Current Ratio

2.05x39.8

Value

P/E (TTM)

—N/A

EV/EBITDA

15.8x46.1

P/FCF

31.8x44.1

P/B

1.9x66.0

P/S

2.4x62.8

Div Yield

—N/A

Momentum

52W High %

84%75.4

RS 6M

-14%48.7

SMA 50/200

1.04x65.2

EPS Rev 4W

+7.0%86.2

EPS Rev 12W

+5.5%80.5

EPS Improve

+412%94.8

Q Growth

391%96.3

FUNDAMENTALS

Market Cap

$12.0B

P/E (Forward)

19.1x

Gross Margin

55.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ELAN are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
ELAN	Elanco Animal Health Incorporated(you)	$12.0B	70	Buy
LQDA	Liquidia Corporation	$6.1B	64	Hold
NBIX	Neurocrine Biosciences, Inc.	$15.7B	85	Strong Buy
ZTS	Zoetis Inc.	$32.0B	66	Buy
VTRS	Viatris Inc.	$18.8B	86	Strong Buy
AMRX	Amneal Pharmaceuticals, Inc.	$6.1B	83	Strong Buy
UTHR	United Therapeutics Corporation	$22.1B	85	Strong Buy
LNTH	Lantheus Holdings, Inc.	$6.6B	88	Strong Buy
PBH	Prestige Consumer Healthcare Inc.	$2.5B	67	Buy
ETON	Eton Pharmaceuticals, Inc.	$1.7B	72	Buy

Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%

Elanco Animal Health Incorporated (ELAN): Stock Score Summary

Elanco Animal Health Incorporated (ELAN) has a MoatMap StockRank of 70/100 based on Quality (45/100), Value (44/100), and Momentum (75/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price	$23.55
Market Cap	$12.0B
P/E (Forward)	19.15
Price/Book	1.86
Return on Equity	-3.0%
Return on Invested Capital	0.7%
Debt/Equity	0.64x
Gross Margin	55.4%
Operating Margin	8.6%
Revenue Growth	10.2%
Free Cash Flow	$379M

Elanco Animal Health Incorporated operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Elanco Animal Health Incorporated’s (ELAN) StockRank?: MoatMap’s StockRank for Elanco Animal Health Incorporated (ELAN) is 70/100, with a Buy signal. It is a composite of Quality (45), Value (44), and Momentum (75) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Elanco Animal Health Incorporated have an economic moat?: Elanco Animal Health Incorporated (ELAN) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Elanco Animal Health Incorporated a buy, hold, or sell?: MoatMap’s current signal for Elanco Animal Health Incorporated (ELAN) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Elanco Animal Health Incorporated in?: Elanco Animal Health Incorporated (ELAN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).